• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative NOL1/NOP2/Sun domain family member 5B (NSUN5P1)

ACP17537

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17537 Target NameNSUN5P1
Target SynonymsNSUN5P1; NSUN5B; WBSCR20B; Putative NOL1/NOP2/Sun domain family member 5B; EC 2.1.1.-; Williams-Beuren syndrome chromosomal region 20B proteinFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-163
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ3KNT7
Background Information
  • Uniprot Id

    Q3KNT7

  • Target Species

    Human

  • Target Name

    NSUN5P1

  • Target Full Name

    Putative NOL1/NOP2/Sun domain family member 5B

  • Target Involvement

    NSUN5P1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.

  • Target Protein Families

    Class I-like SAM-binding methyltransferase superfamily, RsmB/NOP family

  • Target Tissue Specificity

    Ubiquitous.

  • Target Synonyms

    NSUN5P1; NSUN5B; WBSCR20B; Putative NOL1/NOP2/Sun domain family member 5B; EC 2.1.1.-; Williams-Beuren syndrome chromosomal region 20B protein

Inquire Recombinant Human Putative NOL1/NOP2/Sun domain family member 5B (NSUN5P1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification